Eton Pharmaceuticals, Inc. (ETON) Operating income 2018–2025
Eton Pharmaceuticals, Inc. (ETON) annual operating income history from SEC filings — each fiscal year as reported.
-$844,000FY2025 · since FY2018: -$10.3M → -$844,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$844,000 | +67.5% |
| FY2024 | -$2.6M | -117.9% |
| FY2023 | -$1.2M | +85.6% |
| FY2022 | -$8.3M | -452.5% |
| FY2021 | -$1.5M | +94.5% |
| FY2020 | -$27.1M | -45.8% |
| FY2019 | -$18.6M | -80.2% |
| FY2018 | -$10.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice